mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.1 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.072 |
0.1 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.1 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |